Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study
- 16 December 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (6) , 1373-1385
Abstract
Background and Aims: To clarify high‐risk factors and develop a nomogram model to predict biochemical resolution or biochemical nonresolution (BNR) in patients with chronic DILI. Approach and Results: Retrospectively, 3655 of 5326 patients with chronic DILI were enrolled from nine participating hospitals, of whom 2866 underwent liver biopsy. All of these patients were followed up for over 1 year and their clinical characteristics were retrieved from electronic medical records. The endpoint was BNR, defined as alanine aminotransferase or aspartate aminotransferase >1.5× upper limit of normal or alkaline phosphatase >1.1× ULN, at 12 months from chronic DILI diagnosis. The noninvasive high‐risk factors for BNR identified by multivariable logistic regression were used to establish a nomogram, which was validated in an independent external cohort. Finally, 19.3% (707 of 3655) patients presented with BNR. Histologically, with the increase in liver inflammation grades and fibrosis stages, the proportion of BNR significantly increased. The risk of BNR was increased by 21.3‐fold in patients with significant inflammation compared to none or mild inflammation (p < 0.001). Biochemically, aspartate aminotransferase and total bilirubin, platelets, prothrombin time, sex, and age were associated with BNR and incorporated to construct a nomogram model (BNR‐6) with a concordance index of 0.824 (95% CI, 0.798–0.849), which was highly consistent with liver histology. These results were successfully validated both in the internal cohort and external cohort. Conclusions: Significant liver inflammation is a robust predictor associated with biochemical nonresolution. The established BNR‐6 model provides an easy‐to‐use approach to assess the outcome of chronic DILI.Keywords
Funding Information
- National Natural Science Foundation of China (81630100)
This publication has 39 references indexed in Scilit:
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryAmerican Journal of Gastroenterology, 2014
- Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From OnsetGastroenterology, 2014
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver InjuryGastroenterology, 2014
- Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical AssociationsHepatology, 2014
- Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of IcelandGastroenterology, 2013
- Drug-Induced Acute Liver FailureHepatology, 2010
- Pharmacogenetics of drug‐induced liver injury†Hepatology, 2010
- Risk Factors for Idiosyncratic Drug-Induced Liver InjuryGastroenterology, 2010
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981